Visit to Africa Obama more funding for microbicides

Visit to Africa Obama more funding for microbicides, HIV / AIDS Education, Nutrition Programs Call says consultant, U.S . Senator Barack Obama on his visit to Kenya and South Africa in a two-week visit to Africa, told he wanted of of HIV / AIDS funding for nutrition for HIV-positive people, and support for HIV / AIDS education and public relations campaigns and the development of microbicides, after Obama’s foreign policy adviser Mark Lippert, the AP / Belleville News Democrat reports (Wills, AP / Belleville News Democrat as part of a as part of a congressional delegation, on Saturday publicly Kenya took an HIV test to help combat the stigma of the virus. The senator CDC CDC take the test. Take the test. His wife, Michelle, also received an HIV test, and both tests were negative. The couple underwent counseling after the test to encourage other couples (do Kaiser Daily HIV / AIDS Report, after Obama’s public HIV test, said Michael Ranneberger, the U.S. Ambassador to Kenya, and a popular politician in the Kisumu area, they plan an HIV test, which undergo AP / News Democrat reports. Peter Agulo – Mayor of Homa Bay, Kenya – Obama said leaders in the country will be HIV test encourage people encourage people to get tested, added that many people are now ‘to come without fear ‘to know their HIV status to learn. In addition, said HIV / AIDS advocates, who met with Obama during his trip they want to avoid the training youth on the high-risk behavior and support for HIV-positive people to focus to increase combat the spread of the virus, according to the AP / News Democrat. ‘I see nothing but upsides for the fight against HIV in Senator Obama’s visit, ‘Drew Altman, president and CEO of the Kaiser Family Foundation, and added: ‘The senator focused on the underlying cultural, social and economic issues such as stigma and the rights of women is right on target ‘(AP / Belleville News Democrat.

The U.S. Patent androves Watson generic version of Seasonale pill Barr; Both firms start generic versionsFDA has on Thursday reported Watson Pharmaceuticals Drug Application for its generic version of Barr Laboratories ‘ extended – cycle oral contraceptive Seasonale, Reuters. A Barr daughter launches Jolessa version that will be sold under the name Jolessa . FDA approved Seasonale, which allow users number of annual number of annual menstrual from 13 to four, in September 2003 allows. Women take 84 active pills and then successively to seven placebo pills as compared with the conventional therapy of 21 active pills through seven placebo. The U.S. Patent and Trademark Office May rejected Barr desire to exhibit his patent on Seasonale. Barr subsidiary Duramed Pharmaceuticals received a final rejection from the patent office, the company has three months in which to problems caused by the government before the company three year product guarantee exclusivity ended on 5 September . Watson – who said in 2004 filed a marketing application with FDA that the Duramed Seasonale patent was unenforceable and void – there was immediately launches its product, which is sold under the name Quasense, MarketWatch reports. According to MarketWatch, Watson is the first pharmaceutical company to successfully challenge Barr Seasonale patent and market exclusivity for 180 days have. – Courtesy of you, the entire Kaiser Daily Health Policy view Report, search the archives, or sign up for email delivery at Kaiser Daily Health Policy Report strongly supported kaiser network a free service of The Henry J. Published. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Narrated by editor Philip M. MPHUroToday – the sole urology site by original content from global urological key opinion leader write written clinical practices.